My take is that Ben Lurkin has some kind of a vendetta with

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
774
My take is that Ben Lurkin has some kind of a vendetta with the CEO either because he lost money in the past due to being an inept trader or was part of a deal gone wrong. There is no excuse for anyone to have lost money on INCC since 2014 if traded properly due to the windfall opportunity offered to load in the .0002>0020 range after it was shorted down from .0219 in 3Q 2014.

Everything he posts is nonsense and can be disproved with elementary math or just plain common sense.

For instance:

The CEO has not "lost" or "taken" $30M in shareholders' money - $INCC cannot possibly have traded $30M in the entire life of all its incarnations. Traders lose money by choosing to sell for a cheaper price than they bought at because they are impatient or don't trade from the bottom up.

There is no selling of shares by the company - as evidenced by the trading action.

Nobody could have bought a $1M home with profits from $INCC even if they sold every single share traded in the last 6 months for way above the average price during that period.

I made numerous complaints to iHub Admin about Lurkin misusing his Moderator position - including trying to delete my posts several times after I reinstated them myself several times - and incorrect deletions of the posts of others - and nothing was done. Many boards on iHub have been reduced to a joke by a combination of the appointment of basher Mods, corrupt iHub Admin and inadequate TOS that allow deliberately misleading posts to remain up.

Investors Hangout is a much better site for serious traders with only credible Moderators being appointed, far more stringent TOS, a prohibition on the posting of deliberately misleading information or scaremongering, and bashers can be banned instantly. It also now has superior features compared to iHub free such as trade details for those without Level 2 and the news function straight to boards.

Tersis Technologies, Inc. (TERS) Stock Research Links

TERS Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Caldolor®: A Breakthrough in Opioid-Sparing Pain Relief for Seniors

Updated Category News Views 183

Revolutionizing Pain Management for Older Adults This comprehensive analysis reveals groundbreaking findings about Caldolor® (intravenous ibuprofen) and its effectiveness in managing pain for older adults. As the population ages, the need for safer alternatives for pain relief has significantly increased. Recent studies showcase a marked reduction in opioid consumption...

Continue Reading
Certara Stock Faces Challenges as it Hits a 52-Week Low

Updated Category News Views 120

Certara's Stock Market Performance Certara Inc. (NASDAQ: CERT), recognized as a frontrunner in biosimulation technology, has recently seen its stock price fall to a concerning 52-week low of $10.35. This price decline highlights a notable shift from its previous valuation, indicating a tumultuous time for shareholders. Over the last year, Certara's stock has experienced a...

Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline

Updated Category News Views 159

Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...

Continue Reading
Nebraska Medicine Enhances Cancer Services with Expansion

Updated Category News Views 82

Nebraska Medicine Strengthens Cancer Care Network Nebraska Medicine is making significant strides in enhancing cancer care with the introduction of its new facility, Nebraska Medicine Fred & Pamela Buffett Cancer Center – Kearney. This expansion aims to serve communities across various regions, and it heralds an exciting phase for cancer treatment and research in the...

Continue Reading
Sunshine Silver's IPO: A Spotlight on Silver's Future

Updated Category News Views 8

Sunshine Silver Steps into the Spotlight Ah, the thrill of a fresh IPO. Sunshine Silver Mining & Refining Company, rolling under the ticker SSMR, has announced its initial public offering price—$13.50 a share, with 20 million shares up for grabs. This development has sure piqued the interest of traders eyeing some silver lining. The Figures That Matter Alright, let’s...

Continue Reading